1. Finkel, Richard S, Mercuri, Eugenio, Darras, Basil T, Farwell, Wildon, De Vivo, Darryl C. . Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. In The New England journal of medicine, 377, 1723-1732. doi:10.1056/NEJMoa1702752. https://pubmed.ncbi.nlm.nih.gov/29091570/
2. Mercuri, Eugenio, Darras, Basil T, Chiriboga, Claudia A, De Vivo, Darryl C, Finkel, Richard S. . Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. In The New England journal of medicine, 378, 625-635. doi:10.1056/NEJMoa1710504. https://pubmed.ncbi.nlm.nih.gov/29443664/
3. Huang, Longping, Sun, Jian, Ma, Yuteng, Tian, Chen, Dong, Ming. 2024. MSI2 regulates NLK-mediated EMT and PI3K/AKT/mTOR pathway to promote pancreatic cancer progression. In Cancer cell international, 24, 273. doi:10.1186/s12935-024-03444-9. https://pubmed.ncbi.nlm.nih.gov/39097735/
4. Liu, Ruijie, Khalil, Hadi, Lin, Suh-Chin J, York, Allen J, Molkentin, Jeffery D. 2016. Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart. In PloS one, 11, e0164897. doi:10.1371/journal.pone.0164897. https://pubmed.ncbi.nlm.nih.gov/27764156/